US 7,001,922 B2Granted

Peptide deformylase activated prodrugs

AssigneeCelmed Oncology (USA), Inc.

InventorsCarlo Ballatore, Maria V. Sergeeva, Venkata Ramana Doppalapudi

Life of this patent

Estimating the term…

Abstract

The invention provides compounds and methods for using them to inhibit the growth of microorganism that expresses Peptide Deformylase, the compounds having the general formula:

Claims2

Dependent claims

A compound having the structure:

Dependencies are inferred from the claim text.

Facts

Application: 10/714,255Filed 14 Nov 2003 · us provisional application
Priority: 14 Nov 2002
Published: US 2004/0236096 A125 Nov 2004
Granted: 21 Feb 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07F 9/4084
The ester moiety containing a substituent or a structure which is considered as characteristic: esters with hydroxyaryl compounds
A61K 47/65
The modifying agent being a protein, peptide or polyamino acid: peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00
C07F 9/4006
The acid moiety containing a substituent or a structure which is considered as characteristic: esters of acyclic acids which can have further…

Family

Application60/426,771Us provisional application · filed 14 Nov 2002
US 2004/0236096 A1Pre-grant publication · published 25 Nov 2004
US 7,001,922 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…